(Q74024097)
Statements
The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model (English)
Chabaud M
scientific article published on 01 June 2001